5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbonitrile, 95.0%, 25g

Methyl 3-formyl-2-methoxybenzoate, 95.0%, 25mg

[2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methoxyphenyl]boronic acid hydrochloride, 95.0%, 250mg

Gastight syringe with screw head connection, 5.0 ml, 1 piece

3-Amino-4-(isobutylamino)quinoline Hydrochloride>98.0%(HPLC)(T)1g

N-Isopropyltetrahydrothiophen-3-amine 1,1-dioxide hydrochloride, 95.0%, 1g

Sodium 3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-bis(olate), 95.0%, 250g

Activated carbon, pa, powder, activated, 500 g, plastic packaging.

(S)-4-(Benzo[b]thiophen-3-yl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 97%, 1g

3-AMINO-4-BROMOBENZONITRILE, 95.0%, 250mg

(R)-SPINOL, 25g

N-(4-Bromophenethyl)-2,2,2-trifluoroacetamide, 98%, 500mg

4-(2,4-Dimethylphenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid, 98%, 25mg